Medicaid, GAO, Drug Pricing

Washington Healthcare Update - May 2024

McGuireWoods Consulting on 5/7/2024

This Week in Washington: Senate Finance Committee releases discussion draft concerning generic drug shortages; FDA releases laboratory-developed tests final rule; Administration extends ACA subsidies for Deferred Action for...more

McDermottPlus Check-Up: April 17, 2024

McDermott+ on 4/18/2024

House Energy & Commerce Health Subcommittee Holds Hearing on Cybersecurity. During the hearing, there was bipartisan concern about UnitedHealth Group’s response to the Change Healthcare cyberattack and consensus around the...more

Washington Healthcare Update - February 2024

McGuireWoods Consulting on 2/8/2024

This Week in Washington: CMS releases 2025 MA and Part D proposed payment Advance Notice; CMS sends first fair drug price offers to Drug Price Negotiation Program companies; SAMHSA releases final rule making virtual...more

Washington Healthcare Update - June 2023 #2

McGuireWoods Consulting on 6/13/2023

This Week in Washington: Fallout from debt ceiling holds up House floor action; SCOTUS rules to allow patients to sue nursing homes...more

Holland & Knight Health Dose: May 16, 2023

Holland & Knight LLP on 5/19/2023

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector. ...more

Washington Healthcare Update - May 2022 #4

McGuireWoods Consulting on 6/1/2022

Congress - The House and Senate are in recess for Memorial Day. House - Rep. Underwood Leads 26 Democratic House Members in Letter Calling for Measures to Lower Healthcare Costs to be Included in Reconciliation...more

Washington Healthcare Update - August 2021 #3

McGuireWoods Consulting on 8/17/2021

This week in Washington: Senate passes infrastructure bill; Senate passes budget resolution with reconciliation instructions; Congress enters recess with House members to return Aug. 23....more

Healthcare & Life Sciences: Drug Pricing Digest - June 2021 #2

Latham & Watkins LLP on 6/22/2021

Supreme Court Upholds Affordable Care Act: On June 17, 2021, the Supreme Court ruled 7 to 2 to dismiss for lack of standing a challenge to the Affordable Care Act (ACA) brought by Texas and other states. The states had...more

Washington Healthcare Update - December 2020 #2

McGuireWoods Consulting on 12/15/2020

This week in Washington: Congress passes funding bill for an additional week to come up with full-year spending legislation to avoid a government shutdown....more

The 340B Contract Pharmacy Saga

Foley Hoag LLP - Medicaid and the Law on 9/24/2020

We are back again with another 340B post. The 340B program has recently been a regular feature on the blog in the context of ongoing litigation discussed here and here. Today, we wanted to provide readers the details of an...more

340B and Medicaid: Scope, Vulnerabilities and New Survey Findings

Manatt, Phelps & Phillips, LLP on 3/4/2020

The 340B Program’s Growing Scope - The 340B program has grown significantly in scope. According to the Health Resources and Services Administration (HRSA), as of January 1, 2018, the 340B program included 12,823 providers...more

GAO Recommends CMS, HRSA Improve 340B Duplicate Discount Oversight

McDermott Will & Emery on 2/5/2020

On January 27, the Government Accountability Office (GAO) published a report concluding that the US Department of Health and Human Services (HHS) has provided limited oversight of the 340B and Medicaid Drug Rebate Programs,...more

A Flurry of Recent Activity Highlights Continued Interest in 340B Program Oversight

Baker Donelson on 1/30/2020

Four separate government releases coming over a three-week period have once again highlighted the intense interest in the 340B drug pricing program, with a federal agency and two government watchdog groups issuing guidance...more

2020 Starts Off with Two Government Publications Critical of 340B Program Oversight

McDermott Will & Emery on 1/14/2020

Less than two weeks into the new year, the federal government has released two new publications addressing concerns related to 340B Program oversight by both state and federal agencies. After a relatively quiet 2019, 340B...more

Washington Healthcare Update - November 2019 #1

McGuireWoods Consulting on 11/5/2019

This week in Washington: Senate to hold a hearing on the response to lung illness and rising youth electronic cigarette use, as well as a hearing on protecting veterans from a variety of scams, including fake charities....more

Washington Healthcare Update June 2019 #1

McGuireWoods Consulting on 6/11/2019

This week in Washington: Senate to consider state of patent eligibility in America, House Ways and Means Committee will hold a hearing on the single-payer issue and both the House and Senate continue to hold hearings on the...more

340B In The Spotlight – Key Program Developments

Polsinelli on 5/16/2019

In this issue, Polsinelli’s 340B and Reimbursement teams provide an update on the most recent developments in the ongoing 340B /Part B Payment litigation and also highlight recent Government Accountability Office (“GAO”)...more

Washington Healthcare Update: January 2019 #3

McGuireWoods Consulting on 1/23/2019

This Week: The government shutdown continues; Congress finishes organizing and finalizing committee members and begins to focus on the issues. Concern has been raised that the Centers for Medicare and Medicaid Innovation...more

July 2018: Where Are We Now With 340B?

Mintz - Health Care Viewpoints on 7/17/2018

It seems like every week, there are multiple new developments in the 340B program. While it has just been a few weeks since my last 340B blog post, since that time we have had another Senate hearing, a new GAO Report, a new...more

Capitol Hill Healthcare Update

BakerHostetler on 6/26/2018

LAWMAKERS COOL TO TRUMP PLAN ON HHS, GOVERNMENT REORGANIZATION - The response from lawmakers on Capitol Hill to the White House plan to reorganize the federal government – including proposed changes to multiple healthcare...more

Capitol Hill Healthcare Update

BakerHostetler on 6/19/2018

HOUSE OKs DOZENS OF OPIOID-RELATED BILLS; MORE VOTES SCHEDULED - The House last week approved 38 bills that lawmakers hope will stem the opioid epidemic, and it scheduled votes this week on at least a dozen more....more

Health Care Weekly Preview from ML Strategies – March 2018 #2

Mintz - Health Care Viewpoints on 3/13/2018

This week, Congress returns to Washington with 11 days to finalize a government spending bill. House appropriators will be meeting throughout the week to finalize their respective packages which means we should expect to see...more

White House Unveils Proposal on Drug Pricing

Holland & Knight LLP on 2/13/2018

On Feb. 9, 2018, the Trump Administration released a 30-page report analyzing domestic and global factors influencing drug pricing. The report by the Council of Economic Advisers (CEA) is expected to inform the HHS' Fiscal...more

This Year May be a Game Changer for 340B Drug Discount Program, Take Two

Mintz - Health Care Viewpoints on 1/18/2018

I previously said that the year 2014 may be a game-changer for the 340B Drug Discount Program. Increasing HRSA audits, a lawsuit over the 340B Orphan Drug Rule, and HRSA’s promise to issue a 340B mega-regulation, all pointed...more

Witnesses at Congressional Hearing on 340B Urge Congress To Give HRSA Broader Regulatory Authority

Mintz - Health Care Viewpoints on 7/26/2017

On July 18, 2017, just days after CMS went public with its proposal to reduce Medicare Part B reimbursement to certain 340B covered entities, Congress held its first hearing on 340B Program Oversight since March 2015. A...more

Medicaid › Government Accountability Office › Drug Pricing

"My best business intelligence, in one easy email…"